Tivic Health Systems, Inc. financial data

Symbol
TIVC on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
47685 Lakeview Blvd, Fremont, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 550 % +30.9%
Quick Ratio 107 % +52.3%
Debt-to-equity 21.8 % -37.2%
Return On Equity -193 % -3.71%
Return On Assets -159 % -14.7%
Operating Margin -726 % -3.52%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 620K shares -57.7%
Common Stock, Shares, Outstanding 557K shares +546%
Entity Public Float 3M USD -76.9%
Common Stock, Value, Issued 1K USD
Weighted Average Number of Shares Outstanding, Basic 287K shares +516%
Weighted Average Number of Shares Outstanding, Diluted 287K shares +516%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 780K USD -33.7%
Cost of Revenue 778K USD -12.5%
Research and Development Expense 1.31M USD -20.7%
Selling and Marketing Expense 1.19M USD -44.1%
General and Administrative Expense 3.16M USD -33.4%
Operating Income (Loss) -5.66M USD +31.3%
Nonoperating Income (Expense) 0 USD
Net Income (Loss) Attributable to Parent -5.66M USD +31.4%
Earnings Per Share, Basic -19.7 USD/shares +88.9%
Earnings Per Share, Diluted -19.7 USD/shares +88.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2M USD -41%
Accounts Receivable, after Allowance for Credit Loss, Current 69K USD -60.3%
Inventory, Net 319K USD -57.8%
Assets, Current 2.64M USD -43.3%
Property, Plant and Equipment, Net 119K USD -2.46%
Operating Lease, Right-of-Use Asset 304K USD -36.8%
Other Assets, Noncurrent 34K USD 0%
Assets 2.81M USD -45.6%
Accounts Payable, Current 125K USD -82.5%
Employee-related Liabilities, Current 40K USD
Liabilities, Current 272K USD -80.6%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 272K USD -82.8%
Retained Earnings (Accumulated Deficit) -43.5M USD -14.9%
Stockholders' Equity Attributable to Parent 2.54M USD -29.2%
Liabilities and Equity 2.81M USD -45.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.67M USD +31.3%
Net Cash Provided by (Used in) Financing Activities -61K USD -101%
Net Cash Provided by (Used in) Investing Activities -94K USD -1467%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 557K shares +546%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.73M USD -205%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2M USD -41%
Deferred Tax Assets, Valuation Allowance 8.52M USD +12.4%
Deferred Tax Assets, Gross 8.52M USD +11%
Operating Lease, Liability 321K USD -36.4%
Depreciation 1K USD -50%
Payments to Acquire Property, Plant, and Equipment 94K USD +1467%
Lessee, Operating Lease, Liability, to be Paid 335K USD -38.3%
Property, Plant and Equipment, Gross 159K USD 0%
Operating Lease, Liability, Current 180K USD -1.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 210K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 178K USD -15.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14K USD -63.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 178K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 7.63M USD +12.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 108K USD +10.2%
Operating Lease, Payments 87K USD -57.8%
Additional Paid in Capital 46.1M USD +11.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3K USD -62.5%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 229K USD -15.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%